Search Thermo Fisher Scientific
Urinary Tract Infection (UTI) Testing Research Solutions
PCR-Based Research Use Only (RUO) Panels for UTI Testing
For Research Use Only. Not for use in diagnostic procedures.
Detect slow-growing or difficult-to-culture uropathogens
Including both bacterial and fungal targets across multiple formats
Targeted panels
Targets: 4–9
Examples: Coagulase-negative staphylococci, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus saprophyticus, Candida albicans
Syndromic panels
Targets: 24–56
Examples: Acinetobacter baumannii, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Pseudomonas aeruginosa, Streptococcus agalactiae, Ureaplasma urealyticum, Candida albicans
For Research Use Only. Not for use in diagnostic procedures.
Need help finding the right UTI research testing solution?
Learn more about PCR testing formats like single tube and plates ›
Expand your molecular testing research menu using the PCR instrument you have.
Looking to learn ways you can incorporate UTI testing into your laboratory?
Applied Biosystems TaqMan and TrueMark UTI Research
Urinary tract infections (UTIs) are not only prevalent, but can be recurrent, chronic, and even lethal. Dedicated research using the correct tools for identifying the cause of infection is key to combatting them effectively.
While most common UTIs may be discovered with culture-based methods, the detection of severe, higher-risk UTIs benefits from the added assurance of real-time PCR (qPCR) technology.
PCR, when combined with standard culture methods, allows for a level of sensitivity that can uncover the more dangerous, complicated infections that might otherwise be missed. In addition, because PCR can detect and identify multiple targets, it can reveal the specific pathogens causing the infection and ensure the correct methods are used to combat them. This specificity is a benefit for mitigating all UTIs, especially when choosing an appropriate antibiotic, should one be needed.
Applied Biosystems Urinary Research Panels are real-time PCR panels designed to enable rapid analysis of a wide range of urinary tract microbiota in a scalable, low-cost per sample format in under five hours.
Applied Biosystems TrueMark real-time PCR solution are part of a sample-to-results workflow. Benefits include the ability to:
- Detect and differentiate multiple pathogens
- Obtain reliable real-time PCR results—Accurate, sensitive, and specific
- Select from multiple format options to suit your testing capacity—Choose from single tube assays, 96- or 384-well plates, cards, or OpenArray plates
- Order individual assays, predesigned panels, or customize your own—Select from a catalogue of >600 assays targeting pathogens or resistance genes
- Reduce time-to-implementation—Accelerate and streamline your validation process with Analytical Validation Consulting Services
*
Applied Biosystems TrueMark Urinary Expanded Panel, TaqMan Array Cards
| Targets | |||
| Bacterial | Acinetobacter baumannii Actinobaculum schaalii Aerococcus urinae Alloscardovia omnicolens Citrobacter freundii Citrobacter koseri Coagulase-negative staphylococci Corynebacterium riegelii Enterobacter aerogenes | Enterobacter cloacae Enterococcus faecalis Enterococcus faecium Escherichia coli Klebsiella oxytoca Klebsiella pneumoniae Morganella morganii Mycoplasma hominis Pantoea agglomerans | Proteus mirabilis Proteus vulgaris Providencia stuartii Pseudomonas aeruginosa Serratia marcescens Staphylococcus aureus Streptococcus agalactiae Ureaplasma urealyticum Viridans group streptococci |
| Fungal | Candida albicans Candida auris Candida glabrata Candida parapsilosis | ||
Antibiotic resistance markers | ACC ACT blaOXA-48 CTX-M CMY dfrA1 dfrA5 DHA FOX GES IMP | KPC LAT mecA MOX OXA PER QnrA QnrB QnrS SHV sul1 | sul2 TEM tetM tetS vanA vanA1 vanB vanC VEB VIM |
*This is an early access product. Panel content and format may change prior to launch.
No. of targets | 45 |
Throughput | 8 samples/card |
Control(s) | 18S, Xeno, and B. atrophaeus Extraction Control assays. Use the Comprehensive Microbiota Control (A50382) as an amplification control. |
Sample type(s) | Varies |
Turnaround time | ~4 hours |
Instrument compatibility |
|
Software | Applied Biosystems QuantStudio Design and Analysis Software v2.6 or later |
Cat. No | 4398986 – must be ordered offline through Specialty_Cards@thermofisher.com. (Custom panel options also available) |
Applied Biosystems TrueMark Urinary Expanded Panel, OpenArray Plate
| Targets | |||
| Bacterial | Acinetobacter baumannii Actinobaculum schaalii Aerococcus urinae Alloscardovia omnicolens Citrobacter freundii Citrobacter koseri Coagulase-negative staphylococci Corynebacterium riegelii Enterobacter aerogenes | Enterobacter cloacae Enterococcus faecalis Enterococcus faecium Escherichia coli Klebsiella oxytoca Klebsiella pneumoniae Morganella morganii Mycoplasma hominis Pantoea agglomerans | Proteus mirabilis Proteus vulgaris Providencia stuartii Pseudomonas aeruginosa Serratia marcescens Staphylococcus aureus Streptococcus agalactiae Ureaplasma urealyticum Viridans group streptococci |
| Fungal | Candida albicans Candida auris Candida glabrata Candida parapsilosis | ||
Antibiotic resistance markers | ACC ACT blaOXA-48 CTX-M CMY dfrA1 dfrA5 DHA FOX GES IMP | KPC LAT mecA MOX OXA PER QnrA QnrB QnrS SHV sul1 | sul2 TEM tetM tetS vanA vanA1 vanB vanC VEB VIM |
*This is an early access product. Panel content and format may change prior to launch.
No. of targets | 53 |
Throughput | 24–48 samples/plate |
Control(s) | RNase P, Xeno, and B. atrophaeus Extraction Control assays. Use the Comprehensive Microbiota Control (A50382) as an amplification control. |
Sample type(s) | Varies |
Turnaround time | ~5 hours |
Instrument compatibility | QuantStudio 12K Flex Real-Time PCR System |
Software | QuantStudio 12K Flex Software |
Cat. No | 4470201—must be ordered offline through QuantStudioFrontDesk@thermofisher.com. (Custom panel options also available) |
Applied Biosystems TrueMark Urinary Tract Microbiota Comprehensive Plate, OpenArray
| Targets | ||
Bacterial | Acinetobacter baumannii Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Enterococcus faecalis Enterococcus faecium Escherichia coli Klebsiella oxytoca | Klebsiella pneumoniae Morganella morganii Proteus mirabilis Proteus vulgaris Providencia stuartii Pseudomonas aeruginosa Streptococcus agalactiae Ureaplasma urealyticum |
| Fungal | Candida albicans | |
No. of targets | 17 |
Throughput | 48 samples/plate |
Control(s) | RNase P and Xeno Control assays. Use the TaqMan Urinary Tract Microbiota Amplification Control (A39174) or the Comprehensive Microbiota Control (A50382) as an amplification control. |
Sample type(s) | Varies |
Turnaround time | ~5 hours |
Instrument compatibility | QuantStudio 12K Flex Real-Time PCR System |
Software | QuantStudio 12K Flex Software |
Cat. No | (Custom panel options also available) |
Whether you want to modify from an existing design or start from scratch, we're here to walk you through the process.
Ask about our curated, flexible content panels
Custom TrueMark Urinary I Panel (A55018)
Request a consultation or place an order › Custom TrueMark Urinary II Panel (A55018)
Request a consultation or place an order › Custom TrueMark Urinary III Panel (A55018)
|
Don't see what you're looking for? We offer customization across all formats so you can create a tailored solution that meets your laboratory's throughput and business needs. |
*Spike in the Applied Biosystems TaqMan Universal Extraction Control Organism (Cat. No. A39180) containing Bacillus atrophaeus for use as a process control.
|
|
|
|
| |
Format | Single tube assay | Duplex (target and internal control) TaqMan assays, pre-spotted | Singleplex TaqMan assays, pre-spotted | ||
Number of assays | 1 to 5 | 4 and 8 | 12 and 24 | 24 or 48 | 18–224 |
Number of samples | 1–384 | 12–24 | 16–32 | 1–8 | 12–48 |
Reaction volume | 10 μL, 20 μL | 10 μL, 20 μL | 10 μL | 1 μL | 33 nL |
Sample types | Urine | ||||
Instruments |
|
|
| ||
Turnaround time | <4 hours | <5 hours | |||
Software | QuantStudio Design and Analysis v2.6 or later | QS12K Flex Software | |||
Benefit | Flexibility in sample throughput; load wells only as needed | Panels with multiple targets offer an intermediate approach to testing | Fast, easy setup | Low cost per pathogen for broad pathogen detection studies | |
Predefined |  |
| | | |
Custom | | | | | |
Complete your infectious disease workflow with a single kit for DNA and RNA extraction
Maximize your nucleic acid yield for greater assay sensitivity from a range of biological specimens for infectious disease applications with the MagMAX Prime Viral/Pathogen NA Isolation Kit.
For Research Use Only. Not for use in diagnostic procedures.
Style Sheet for Komodo Tabs
Style Sheet for Global Design System